ERBB2 and breast cancer: In the study by Menendez et al., FASN inhibition by the mycotoxin cerulenin sensitizes SK-BR-3 breast cancer cells to the cytotoxic effect of the anticancer drug docetaxel via downregulation of HER-2/neu oncogene expression [127].